ConductScience.org, home

Trial · NCT00135707

Outcomes38

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYComposite of Pregnancy-associated Hypertension and Serious Adverse Outcomes in the Mother or Fetus or Neonate20 weeks through discharge following deliveryThe analysis was intent to treat.ParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYSevere Hypertension20 weeks through discharge following deliveryParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYSevere or Mild Pregnancy-associated Hypertension With Elevated Liver Enzyme Levels20 weeks through discharge following deliveryParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYSevere or Mild Pregnancy-associated Hypertension With Thrombocytopenia20 weeks through discharge following deliveryparticipantsNUMBER
PRIMARYSevere or Mild Pregnancy-associated Hypertension With an Elevated Serum Creatinine Level20 weeks through discharge following deliveryParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYSevere or Mild Pregnancy-associated Hypertension With an Eclamptic Seizure20 weeks through discharge following deliveryParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYSevere or Mild Pregnancy-associated Hypertension With an Indicated Preterm Birth Before 32 Weeks of Gestation Owing to Hypertension-related Disorders20 weeks through discharge following deliveryParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYSevere or Mild Pregnancy-associated Hypertension With a Fetus That Was Small for Gestational Age (Below the 3rd Percentile) Adjusted for Sex and Race or Ethnic Group20 weeks through discharge following deliveryParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYSevere or Mild Pregnancy-associated Hypertension With a Fetal Death After 20 Weeks of Gestation or Neonatal Death20 weeks through discharge or prior to discharge following delivery admissionParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPreeclampsia (Mild, Severe, HELLP Syndrome, Eclampsia)20 weeks through discharge following deliveryParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPregnancy Associated Hypertension20 weeks through discharge following deliveryParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYMedically Indicated Delivery Because of Hypertension20 weeks through discharge following deliveryParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYAspartate Aminotransferase ≥100 U/Liter20 weeks through dischargeParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCreatinine ≥1.5 mg/dl (133 μmol/Liter)20 weeks through dischargeParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYAntepartum BleedingDuring pregnancyParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPremature Rupture of MembranesDuring pregnancyParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPlacental AbruptionDuring pregnancyParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCesarean DeliveryDeliveryParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYMaternal DeathDelivery through hospital dischargeOne maternal death in each group due to peripartum cardiomyopathy.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPostpartum Pulmonary EdemaAfter delivery through dischargeParticipantsCOUNT_OF_PARTICIPANTS

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00135707/outcomes